Trials / Completed
CompletedNCT06651905
Nerve Block Vs Sedation Infusion for Awake Fiberoptic Intubation.
Superior Laryngeal Nerve Block Versus Sedation with Intravenous Dexmedetomidine Infusion for Awake Fiberoptic Intubation of Hemimandibulectomy Patients with an Anticipated Difficult Airway: a Randomized Controlled Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 80 (actual)
- Sponsor
- Cairo University · Academic / Other
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
This study compares the efficacy and safety of dexmedetomidine infusion versus superior laryngeal nerve block during awake fiberoptic intubation in hemimandibulectomy patients.
Conditions
- Superior Laryngeal Nerve Block
- Sedation
- Dexmedetomidine
- Awake Fiberoptic Intubation
- Hemimandibulectomy
- Anticipated Difficult Airway
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Dexmedetomidine | The patients were given 0.5 mcg /kg dexmedetomidine over 10 min via syringe pump, followed by 0.2-0.7 mcg/kg/hour until the end of intubation according to hemodynamics. |
| DRUG | Superior laryngeal nerve block | The patients received an airway nerve block through bilateral superior laryngeal nerve block and trans-tracheal injection for recurrent laryngeal nerve. |
Timeline
- Start date
- 2024-01-01
- Primary completion
- 2024-09-01
- Completion
- 2024-09-01
- First posted
- 2024-10-22
- Last updated
- 2024-10-23
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT06651905. Inclusion in this directory is not an endorsement.